Post-Traumatic Stress Disorder in Primary Care Practice by Joanne L

Total Page:16

File Type:pdf, Size:1020Kb

Post-Traumatic Stress Disorder in Primary Care Practice by Joanne L 1 Post-Traumatic Stress Disorder in Primary Care Practice by Joanne L. Miller A manuscript submitted in partial fulfillment ofthe requirements for the degree of Master ofNursing Washington State University College ofNursing Vancouver, Washington May, 2000 2 To the Faculty ofWashington State University College ofNursing: The members ofthe committee appointed to examine the manuscript ofJOANNE L. MILLER find it satisfactory and recommend that it be accepted. Renee Hoeksel, RN, PhD, Chair Carol Brown, ARNP, PhD Lorna Schumann, ARNP, PhD 3 Acknowledgements (.,. The author would like to acknowledge the assistance and support ofthe clinical faculty ofWashington State University, Vancouver, Family Nurse Practitioner Program, especially Renee Hoeksel & Carol Brown, and Lorna Schumann, clinical faculty at ICNE, Spokane. Many thanks also go to family, friends, and co-workers who have been supportive and encouraging during the writing ofthis paper and completion ofthe FNP Program. 4 Table of Contents Signature Page . 2 Acknowledgements . 3 Abstract '" .. 5 List oftables . 6 List offigures . 7 Manuscript '" , , . 8 5 Abstract Post-traumatic stress disorder (PTSD) is one of many psychiatric problems that may be evaluated, diagnosed, and managed by the primary care practitioner. Patients with PTSD are being diagnosed and treatment is being sought in a variety ofsettings. There are numerous patient populations that have been identified as having the potential for developing this disorder. PTSD is a disorder where psychological and physiological reactions are closely related. The practitioner must be aware ofdiagnostic criteria and options for treatment for this disorder. 6 List ofTables ew. 1. Diagnostic Criteria for 309.81 Posttraumatic Stress Disorder ... ... ... ... ... ... ..... 27 2. Suggested Screening Questions for Posttraumatic Stress Disorder... ...... .. ...... 30 3. SUD-PTSD Patient Management... ... ... ... ... ..... .... ...... ...... ... .. .. 31 4. Medications for Treatment ofPTSD 32 5. Interviewing Torture Survivors ... ... 34 6. Simple versus Complicated Trauma... ... ... ... ...... .. .... ...... 36 7 List ofFigures 1. Acute Trauma Response '" 37 8 Introduction Post-traumatic stress disorder (PTSD) is one ofmany psychiatric problems that may be evaluated, diagnosed, and managed by the primary care practitioner. The world continues to be a stressful and often violent place to live. New patients with PTSD are being diagnosed daily. Treatment is being sought in a variety ofclinical settings, including inpatient, outpatient, general and psychiatric practices. PTSD is a disorder where psychological and physiological reactions are intertwined. The practitioner must be aware ofdiagnostic criteria and options for treatment for this disorder. Diagnosis PTSD is the best-known psychiatric sequela oftrauma. It was first established as a diagnosis in 1980 and consists ofthree clusters ofsymptoms: reexperiencing, avoidance, and hyperarousal (American Psychiatric Association, 1994). DSM-IV ofthe American Psychiatric Association (pp. 427-429) states: The essential feature ofPTSD is the development ofcharacteristic symptoms following exposure to an extreme traumatic stressor involving direct personal experience ofan event that involves actual or threatened death or serious injury, or other threat to one's physical integrity; or witnessing an event that involves death, injury, or a threat to the physical integrity ofanother person; or learning about unexpected or violent death, serious harm, or threat ofdeath or injury experienced by a family member or other close associate. Peebles-Kleiger and Zerbe (1998) state that whether or not psychiatric symptoms develop depends on the characteristics ofthe traumatic event, a person's psychological health before the trauma and age at the time ofthe trauma, the unique meaning ofthe 9 event to the person, and the support systems during recovery. Table 1 lists all DSM-IV diagnostic criteria for this disorder (American Psychiatric Association, 1994). In addition to these criteria, it must be specified that this episode ofPTSD is acute, chronic or delayed onset. PTSD is acute if the duration ofsymptoms is less than three months. PTSD is chronic ifduration ofsymptoms is three months or more. Delayed onset is diagnosed when onset ofsymptoms is as least 6 months after the traumatic stressor. Williams (1987) describes a theoretical model for understanding acute and chronic PTSD. The acute trauma model (Figure 1) delineates three distinct phases of acute post-trauma reactions: the shock phase, the impact phase, and the recovery phase. The practitioner may encounter a patient at any place along this continuum. Zimmerman and Mattia (1999) found that PTSD is frequently overlooked in routine clinical practice when symptoms ofPTSD are not the presenting complaint. In this prospective study, the investigators sampled 1000 patients for PTSD in a psychiatric outpatient practice. The first 500 were administered a diagnostic screening questionnaire that included a PTSD subscale. In this first group, 7.2% were diagnosed with PTSD and an additional 18.6% ofthe same sample screened positive for PTSD on the questionnaire, but were not diagnosed with PTSD. The next 500 patients were interviewed with the Structured Clinical Interview for DSM-IV (First, Spitzer, Williams & Gibbons, 1997). The diagnosis ofPTSD was two times higher (14.4% vs. 7.2%) in this second group. The strength ofthis study is the large sample size and that it included psychiatric professionals who are trained in use ofthe instruments. 10 The investigators concluded that practitioners might limit their attention to a patient's presenting complaint ofdepression or panic attacks and fail to inquire about a trauma history and symptoms ofPTSD. From the pharmacological perspective, improving the recognition ofPTSD might not have that great an impact, as medications that are effective for depression and anxiety are the same ones that have also been shown to reduce symptoms ofPTSD. The difference in treatment may be in the realm of cognitive-behavioral therapy. IfPTSD is not appropriately recognized, patients may not receive this potentially effective form oftreatment. Even in a specialty such as psychiatry PTSD is often underdiagnosed (Zimmerman & Mattia, 1999). Samson, Bensen, Beck, Price and Nimmer (1999) studied patients in an outpatient primary care facility in a large health maintenance organization (HMO). The sample was drawn from 7444 patients who visited the facility during the study period. A computerized psychiatric screening questionnaire was administered to patients with symptoms ofdepression or anxiety. As a result ofthe screening questionnaire, 296 patients were referred for consultation with a structured interview. Ofthe 296 patients interviewed 114 (38.6%) met criteria for PTSD. The investigators concluded that PTSD is often unrecognized among patients in a primary care setting. Diagnosis ofPTSD can be complicated by several factors. Symptoms can occur months or years after the traumatic event and can persist for years. Symptoms can go away, only to recur years or decades later, often triggered by events psychologically or temporally related to the original incident (peebles-Kleiger & Zerbe, 1998). PTSD can be cyclic and progressive (Samson, Bensen, Beck, Price & Nimmer, 1999). 11 The majority ofpatients with PTSD seek treatment in primary care settings, not mental health settings. In the medical setting, a patient may present with an array of apparently unrelated problems. Andreski, Chilcoat, and Breslau (1998) found that there is a strong association between PTSD and somatization symptoms. In this prospective study a random sample of1200 patients was drawn from the list ofall twenty-one to thirty year-old members ofa large HMO. A total of1007 respondents (84% ofthe sample) were interviewed in their hom~s. Approximately three years after the initial interview, a follow-up interview was conducted that involved 979 ofthe original respondents. Five-year follow-up interviews were also conducted with 979 ofthe 1007 respondents. The investigators concluded that persons with PTSD were at least twice as likely as those with other disorders to have a history ofmultiple somatization symptom groups. Dickinson, deGruy, Dickinson, and Candib (1998) found neither the patient nor practitioner may be aware that the current distress may be linked to events that occurred during developmental years. Since most practitioners do not ask their patients about past abuse, the underlying trauma may likely go unrecognized and treatment ofthe presenting problem may prove inadequate and achieve only transient improvement in the patient's condition. Some patients may be inappropriately diagnosed with personality disorders. Medical service utilization increases after a traumatic event. PTSD patients have more somatic complaints than other patients do. These complaints include musculoskeletal, gastrointestinal, cardiovascular, neurological, and gynecological symptoms. Patients usually seek treatment for specific physical complaints and often do not recognize the connection between the past trauma and present symptoms. 12 Additionally, there is much symptom overlap between PTSD and other psychiatric disorders such as depression, anxiety, substance abuse, and personality disorders. Practitioners may identify symptoms ofanxiety or depression and treat them with medication without diagnosing and specifically treating PTSD. Samson, Bensen, Beck, Price and Nimmer (1999) suggest
Recommended publications
  • Concussion Quality Measurement Set
    Concussion Quality Measurement Set Approved by the Concussion Quality Measurement Work Group on July 6, 2020. Approved by the AAN Quality Measure Subcommittee on July 17, 2020. Approved by the AAN Quality Committee on August 17, 2020. Approved by the American Academy of Neurology Institute Board of Directors on September 4, 2020. 1 Disclaimer Quality measures published by the American Academy of Neurology Institute and its affiliates are assessments of current scientific and clinical information provided as an educational service. The information: 1) should not be considered inclusive of all proper treatments, methods of care, or as a statement of the standard of care; 2) is not continually updated and may not reflect the most recent evidence (new evidence may emerge between the time information is developed and when it is published or read); 3) addresses only the question(s) or topic(s) specifically identified; 4) does not mandate any particular course of medical care; and 5) is not intended to substitute for the independent professional judgment of the treating provider, as the information does not account for individual variation among patients. In all cases, the selected course of action should be considered by the treating provider in the context of treating the individual patient. Use of the information is voluntary. AANI provides this information on an “as is” basis, and makes no warranty, expressed or implied, regarding the information. AANI specifically disclaims any warranties of merchantability or fitness for a particular use or purpose. AANI assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of this information or for any errors or omissions.
    [Show full text]
  • Depression: the Often Overlooked Sequela of Head Trauma
    Cleveland State Law Review Volume 66 Issue 1 Article 6 12-31-2017 Depression: The Often Overlooked Sequela of Head Trauma Samuel D. Hodge Jr. Temple University Jack E. Hubbard Follow this and additional works at: https://engagedscholarship.csuohio.edu/clevstlrev Part of the Bioethics and Medical Ethics Commons, Disability Law Commons, Health Law and Policy Commons, Medical Jurisprudence Commons, and the Psychiatric and Mental Health Commons How does access to this work benefit ou?y Let us know! Recommended Citation Samuel D. Hodge Jr. and Jack E. Hubbard, Depression: The Often Overlooked Sequela of Head Trauma, 66 Clev. St. L. Rev. 31 (2017) available at https://engagedscholarship.csuohio.edu/clevstlrev/vol66/iss1/6 This Article is brought to you for free and open access by the Journals at EngagedScholarship@CSU. It has been accepted for inclusion in Cleveland State Law Review by an authorized editor of EngagedScholarship@CSU. For more information, please contact library.es@csuohio.edu. DEPRESSION: THE OFTEN OVERLOOKED SEQUELA OF HEAD TRAUMA SAMUEL D. HODGE,JR.* &JACK E. HUBBARD** ABSTRACT Depression is a common sequela of head trauma. Approximately half of all individuals with a cranial injury will experience depression within the first year, regardless of the severity of the injury. The ailment is characterized clinically as a mood disorder, often associated with intense feelings of sadness. However, depression is more complex than mood disorders, as many mental and bodily complaints—such as insomnia, fatigue, anxiety, appetite changes, aches and pains, and lack of interest in previously enjoyable activities—are associated with depression. These intense feelings, particularly when combined with despair and hopelessness, can lead to suicide, a dreaded potential complication of depression.
    [Show full text]
  • An Analysis of Deep Vein Thrombosis in 1277 Consecutive Neurosurgical Patients Undergoing Routine Weekly Ultrasonography
    J Neurosurg 118:505–509, 2013 ©AANS, 2013 An analysis of deep vein thrombosis in 1277 consecutive neurosurgical patients undergoing routine weekly ultrasonography Clinical article AKIL P. PATEL, M.D.,1 MICHAEL T. KOLTZ, M.D.,1 CHARLES A. SANSUR, M.D., M.H.SC.,1 MANGLA GULATI, M.D.,2 AND D. KOJO HamILTON, M.D.3 Departments of 1Neurological Surgery and 2Medicine, University of Maryland School of Medicine, Baltimore, Maryland; and 3Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon Object. Patients requiring neurosurgical intervention are known to be at increased risk for deep vein thrombosis (DVT) and attendant morbidity and mortality. Pulmonary embolism (PE) is the most catastrophic sequela of DVT and is the direct cause of death in 16% of all in-hospital mortalities. Protocols for DVT screening and early detection, as well as treatment paradigms to prevent PE in the acute postoperative period, are needed in neurosurgery. The authors analyzed the effectiveness of weekly lower-extremity venous duplex ultrasonography (LEVDU) in patients requiring surgical intervention for cranial or spinal pathology for detection of DVT and prevention of PE. Methods. Data obtained in 1277 consecutive patients admitted to a major tertiary care center requiring neurosur- gical intervention were retrospectively reviewed. All patients underwent admission (within 1 week of neurosurgical intervention) LEVDU as well as weekly LEVDU surveillance if the initial study was normal. Additional LEVDU was ordered in any patient in whom DVT was suspected on daily clinical physical examination or in patients in whom chest CT angiography confirmed a pulmonary embolus. An electronic database was created and statistical analyses performed.
    [Show full text]
  • General Recommendations Regarding
    Guideline for Concussion/Mild Traumatic Brain Injury & Persistent Symptoms Healthcare Professional Version Third Edition Adults (18+ years of age) SECTION 5: General Recommendations Regarding Management of Persistent Symptoms The project team would like to acknowledge the Ontario Neurotrauma Foundation (ONF), who initiated and funded the development of the original guideline, as well as the current update. ONF is an applied health research organization with a focus on improving the quality of lives for people with an acquired brain injury or spinal cord injury, and on preventing neurotrauma injuries from occurring in the first place. ONF uses strategic research funding activity embedded within a knowledge mobilization and implementation framework to build capacity within systems of care. ONF works with numerous stakeholders and partners to achieve its objective of fostering, gathering and using research knowledge to improve care and quality of life for people who have sustained neurotrauma injuries, and to influence policy towards improved systems. The foundation receives its funding from the Ontario Government through the Ministry of Health and Long-Term Care. Please note, the project team independently managed the development and production of the guideline and, thus, editorial independence is retained. © Ontario Neurotrauma Foundation 2018 Ontario Neurotrauma Foundation 90 Eglinton East Toronto, ON, Canada M4P 2Y3 Tel.: 1 (416) 422-2228 Fax: 1 (416) 422-1240 Email: info@onf.org www.onf.org Published May 2018 Cover Photo Credit: Puzzle Image: wallpaperwide.com The recommendations and resources found within the Guideline for Concussion/mTBI & Persistent Symptoms are intended to inform and instruct care providers and other stakeholders who deliver services to adults who have sustained or are suspected of having sustained a concussion/mTBI (mild traumatic brain injury).
    [Show full text]
  • Difficulty Hearing in Noise: a Sequela of Concussion in Children
    Brain Injury ISSN: 0269-9052 (Print) 1362-301X (Online) Journal homepage: http://www.tandfonline.com/loi/ibij20 Difficulty hearing in noise: a sequela of concussion in children Elaine C Thompson, Jennifer Krizman, Travis White-Schwoch, Trent Nicol, Cynthia R LaBella & Nina Kraus To cite this article: Elaine C Thompson, Jennifer Krizman, Travis White-Schwoch, Trent Nicol, Cynthia R LaBella & Nina Kraus (2018) Difficulty hearing in noise: a sequela of concussion in children, Brain Injury, 32:6, 763-769, DOI: 10.1080/02699052.2018.1447686 To link to this article: https://doi.org/10.1080/02699052.2018.1447686 Published online: 08 Mar 2018. Submit your article to this journal Article views: 65 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=ibij20 BRAIN INJURY 2018, VOL. 32, NO. 6, 763–769 https://doi.org/10.1080/02699052.2018.1447686 Difficulty hearing in noise: a sequela of concussion in children Elaine C Thompsona,b, Jennifer Krizmana,b, Travis White-Schwocha,b, Trent Nicola,b, Cynthia R LaBellaf,g, and Nina Krausa, b,c,d,e aAuditory Neuroscience Laboratory, Northwestern University, Evanston, IL, USA; bDepartment of Communication Sciences, Northwestern University, Chicago, IL, USA; cInstitute for Neuroscience, Northwestern University, Evanston, IL, USA; dDepartment of Neurobiology, Northwestern University, Evanston, IL, USA; eDepartment of Otolaryngology, Northwestern University, Evanston, IL, USA; fDivision of Pediatric Orthopaedics & Sports Medicine, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA; gDepartment of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA ABSTRACT ARTICLE HISTORY Objective: Concussions can result in auditory processing deficits even in the absence of hearing loss.
    [Show full text]
  • Vaccine Injury Table
    Vaccine Injury Table Applies Only to Petitions for Compensation Filed under the National Vaccine Injury Compensation Program on or after March 21, 2017 (a) In accordance with section 312(b) of the National Childhood Vaccine Injury Act of 1986, title III of Public Law 99-660, 100 Stat. 3779 (42 U.S.C. 300aa-1 note) and section 2114(c) of the Public Health Service Act, as amended (PHS Act) (42 U.S.C. 300aa-14(c)), the following is a table of vaccines, the injuries, disabilities, illnesses, conditions, and deaths resulting from the administration of such vaccines, and the time period in which the first symptom or manifestation of onset or of the significant aggravation of such injuries, disabilities, illnesses, conditions, and deaths is to occur after vaccine administration for purposes of receiving compensation under the Program. Paragraph (b) of this section sets forth additional provisions that are not separately listed in this Table but that constitute part of it. Paragraph (c) of this section sets forth the qualifications and aids to interpretation for the terms used in the Table. Conditions and injuries that do not meet the terms of the qualifications and aids to interpretation are not within the Table. Paragraph (d) of this section sets forth a glossary of terms used in paragraph (c). Time period for first symptom or manifestation of onset or of Illness, disability, injury significant aggravation after Vaccine or condition covered vaccine administration I. Vaccines containing tetanus toxoid (e.g., A. Anaphylaxis ≤4 hours. DTaP, DTP, DT, Td, or TT) B. Brachial Neuritis 2-28 days (not less than 2 days and not more than 28 days).
    [Show full text]
  • Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19
    viruses Case Report Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19 Yesha H. Parekh 1, Nicole J. Altomare 1 , Erin P. McDonnell 1 , Martin J. Blaser 2,3,* and Payal D. Parikh 3,* 1 Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA; yhp7@rwjms.rutgers.edu (Y.H.P.); nja71@rwjms.rutgers.edu (N.J.A.); em912@rwjms.rutgers.edu (E.P.M.) 2 Center for Advanced Biotechnology and Medicine, Rutgers University, New Brunswick, NJ 08901, USA 3 Department of Medicine, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ 08851, USA * Correspondence: martin.blaser@cabm.rutgers.edu (M.J.B.); parikhpd@rwjms.rutgers.edu (P.D.P.) Abstract: Infection with SARS-CoV-2 leading to COVID-19 induces hyperinflammatory and hyper- coagulable states, resulting in arterial and venous thromboembolic events. Deep vein thrombosis (DVT) has been well reported in COVID-19 patients. While most DVTs occur in a lower extremity, involvement of the upper extremity is uncommon. In this report, we describe the first reported patient with an upper extremity DVT recurrence secondary to COVID-19 infection. Keywords: SARS-CoV-2; COVID-19-associated coagulopathy; coagulation disorders; venous thromboembolism 1. Introduction Citation: Parekh, Y.H.; Altomare, The COVID-19 pandemic, due to severe acute respiratory syndrome-coronavirus-2 N.J.; McDonnell, E.P.; Blaser, M.J.; (SARS-CoV-2) has had worldwide consequences [1]. The clinical and pathological features Parikh, P.D. Recurrence of Upper of the infection are gradually becoming better understood [2]. While COVID-19 infects Extremity Deep Vein Thrombosis the respiratory tract and presents as pneumonia in most patients, others also suffer from Secondary to COVID-19.
    [Show full text]
  • Medical Policy Outpatient Cognitive Rehabilitation
    Medical Policy Outpatient Cognitive Rehabilitation Table of Contents Policy: Commercial Coding Information Information Pertaining to All Policies Policy: Medicare Description References Authorization Information Policy History Policy Number: 660 BCBSA Reference Number: 8.03.10 Related Policies Sensory Integration Therapy, #659 Policy Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Medicare HMO BlueSM and Medicare PPO BlueSM Members Outpatient cognitive rehabilitation (as a distinct and definable component of the rehabilitation process) may be MEDICALLY NECESSARY in the rehabilitation of patients with traumatic brain injury. Outpatient cognitive rehabilitation (as a distinct and definable component of the rehabilitation process) is INVESTIGATIONAL for all applications, including, but not limited to, stroke, post-encephalitic or post- encephalopathy patients, autism spectrum disorders, seizure disorders, and the aging population, including Alzheimer’s patients. Prior Authorization Information Pre-service approval is required for all inpatient services for all products. See below for situations where prior authorization may be required or may not be required for outpatient services. Yes indicates that prior authorization is required. No indicates that prior authorization is not required. Outpatient Commercial Managed Care (HMO and POS) No Commercial PPO and Indemnity No Medicare HMO BlueSM No Medicare PPO BlueSM No 1 CPT Codes / HCPCS Codes / ICD-9 Codes The following codes are included below for informational
    [Show full text]
  • Neuropsychological Sequela of Mild Traumatic Brain Injury: a Contemporary Meta-Analytic Review David E
    Marquette University e-Publications@Marquette Dissertations (2009 -) Dissertations, Theses, and Professional Projects Neuropsychological Sequela of Mild Traumatic Brain Injury: A Contemporary Meta-Analytic Review David E. Marra Marquette University Recommended Citation Marra, David E., "Neuropsychological Sequela of Mild Traumatic Brain Injury: A Contemporary Meta-Analytic Review" (2019). Dissertations (2009 -). 887. https://epublications.marquette.edu/dissertations_mu/887 NEUROPSYCHOLOGICAL SEQUELA OF MILD TRAUMATIC BRAIN INJURY: A CONTEMPORARY META-ANALYTIC REVIEW by David E. Marra, MS A Dissertation submitted to the Faculty of the Graduate School, Marquette University, in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Milwaukee, Wisconsin December 2019 ABSTRACT NEUROPSYCHOLOGICAL SEQUELA OF MILD TRAUMATIC BRAIN INJURY: A CONTEMPORARY META-ANALYTIC REVIEW David E. Marra, MS Marquette University, 2019 Mild traumatic brain injuries (MTBIs) result in a constellation of non-specific physical, cognitive, and psychological symptoms. There is significant variability in neurocognitive recovery after MTBI, ranging from a few days to a few months, and others who fail to make complete recovery. A broad literature has attempted to elucidate what individual differences explain this variability. The present study sought to build upon previous meta-analyses, which systematically aggregated and examine relevant literature, by including a more heterogenous population and utilizing contemporary meta- analytic techniques. Three online databases (PsychINFO, PubMed, MedLine) were searched for pertinent studies. Separate random-effects Analogue-to-ANOVA were utilized to examine the overall neurocognitive effects of MTBI across time points, stratified by age, psychological comorbidity, populations of interest (athletes, general medical referrals, Veterans, litigants), and whether performance validity tests (PVT) were utilized. Subsequent analyses utilized meta-regressive techniques to simultaneously examine the variables of interest.
    [Show full text]
  • Association of Airflow Limitation with Trauma Exposure and Post-Traumatic Stress Disorder
    Eur Respir J 2011; 37: 1068–1075 DOI: 10.1183/09031936.00028010 CopyrightßERS 2011 Association of airflow limitation with trauma exposure and post-traumatic stress disorder C. Spitzer*, B. Koch#, H.J. Grabe", R. Ewert#, S. Barnow+, S.B. Felix#, T. Ittermann1, A. Obst#,H.Vo¨lzke1, S. Gla¨ser# and C. Scha¨per# ABSTRACT: Trauma exposure and post-traumatic stress disorder (PTSD) are associated with AFFILIATIONS self-reported asthma and chronic obstructive pulmonary disease. However, these conditions have *Dept of Psychosomatic Medicine and Psychotherapy, University not yet been related to objective measures of lung function. Medical Center Hamburg-Eppendorf 1,772 adults from the general population were assessed regarding their medical histories and and Scho¨n Klinik Hamburg-Eilbek, spirometric lung function. Additionally, they were administered a PTSD interview, and assigned to Hamburg, # three groups: no trauma; trauma, but no PTSD; and trauma with PTSD. Dept of Internal Medicine B – Cardiology, Pulmonary Medicine, Adjusting for sociodemographic, clinical and lifestyle factors, subjects with PTSD had Infectious Diseases and Intensive significantly higher odds ratios for most asthma-related symptoms than PTSD-negative Care Medicine, " participants (OR 3.2–8.8). The mean ratio of forced expiratory volume in 1 s (FEV1) to forced Dept of Psychiatry and vital capacity (FVC) was lowest in the PTSD group and highest in those without trauma exposure. Psychotherapy, 1Institute for Community Medicine, 1 1 Traumatic stress was independently associated with FEV and FEV /FVC. Participants with PTSD, Ernst-Moritz-Arndt-University, compared with those without, had a significantly increased risk for airflow limitation independent Greifswald, and of its definition (OR 4.2–7.8).
    [Show full text]
  • Motor Sequelae of Dementia
    Motor Sequela of Dementia, Devi 1 Motor Sequela of Dementia Gayatri Devi, MD Motor Disorders, 2nd Edition by David S. Younger, MD, Editor. Lippincott Williams & Wilkins, Philadelphia © 2005. Address for correspondence: The NY Memory and Healthy Aging Services 65 East 76th Street New York, NY 10021-1844 Tel: (212) 517 6881 Fax: (212) 517 6921 Motor Sequela of Dementia, Devi 2 Introduction: Consideration of motor disorders in patients with dementia is of clinical importance in establishing the etiopathogenesis of dementia in affected patients, and in many instances, in determining disease progression and prognosis. The motor manifestations may vary from mild extrapyramidal rigidity to paralysis depending on the type and the stage of the dementia. For example, patients with Alzheimer disease (AD) develop parkinsonian features and motor difficulties later in their illness; such symptoms at onset should prompt consideration of dementia due to Lewy bodies (DLB) or another type of dementia1,2. An alternative reason would be a more aggressive type of AD, often associated with a worse prognosis3,4. This chapter addresses motor disorders early and late in the course of dementia of various causes along with the epidemiology, pathophysiology and available treatments. The dementias associated with acquired immunodeficiency syndrome, normal pressure hydrocephalus, and motor neuron diseases are covered elsewhere. Alzheimer Disease: While the pathology is identical, AD can be divided into two clinically different phenotypes defined by different genotypes, namely early onset AD (EOAD), with age at onset prior to the age of 60, and late onset AD (LOAD), with an onset after 60 to 65 years5,6. About 5% of cases of AD are of the EOAD type.
    [Show full text]
  • Coding for ICD-10-CM: More of the Basics
    Centers for Medicare & Medicaid Services MLN Connects™ Video Transcript 12/1/14 Coding for ICD-10-CM: More of the Basics Leah Nguyen Intro I am Leah Nguyen, from the Provider Communications Group here at CMS. I would like to welcome you to today’s MLN Connects video on the US Clinical Modification of the International Classification of Diseases, 10th Edition or ICD-10-CM. The objective of this video is to enhance viewers’ understanding of the characteristics and unique features of ICD-10-CM and similarities and differences between ICD-9-CM and ICD-10-CM. This video is not intended to serve as a substitute for comprehensive coder training necessary for proficient ICD-10-CM coding. As our special guest speakers today, we have Sue Bowman, Senior Director, Coding Policy and Compliance for the American Health Information Management Association, and Nelly Leon-Chisen, Director of Coding and Classification at the American Hospital Association. Before we get started discussing the features of ICD-10-CM, could you tell us, Sue, how providers can obtain an ICD-10-CM code book? Sue Thank you, Leah, I would be happy to. ICD-10-CM code books are widely available at low cost from a number of vendors, in a variety of formats, including paper, electronic, and mobile applications. Code book publishers often add tools or features to facilitate accurate coding. A PDF version is also available free of charge from the National Center for Health Statistics. Leah Thank you, Sue. It sounds like there are a number of options for finding the right code book to meet your needs.
    [Show full text]